Respirology

Article	Citations
P4‐13: Assessment of the impact of atmospheric air microsuspensions on the respiratory function of patients with chronic obstructive pulmonary disease	127
O5‐5: Current smoking by socioeconomic status in a representative Japanese population	109
P6‐17: Effectiveness of inhaled hypertonic saline application for sputum induction to improve Mycobacterium tuberculosis (MTB) identification in patients with pulmonary tuberculosis	89
P5‐109: A fatal case of multiple mycotic pulmonary artery aneurysms due to Aspergillus terreus in a post COVID‐19 patient	86
O18‐3: Analysis of nocturnal desaturation waveform by using algorithm in the patients with idiopathic pulmonary fibrosis	73
P8‐177: Chest wall Ewing's sarcoma – A diagnostic and therapeutic adventure	71
P7‐65: Correlation between body mass index (BMI) and chronic obstructive pulmonary disease (COPD)	71
P11‐14: Blood gas analysis and alveolar‐arterial gradient as predictor of mortality confirmed COVID‐19 patients outcome in Tertiary Referral Hospital	51
P5‐43: A case of hyperpyrexia of hypothalamic origin associated with severe COVID‐19 pneumonia in pregnancy	50
P10‐12: Risk factors for poor sleep quality and excessive daytime sleepiness in late pregnancy: A preliminary analysis of a cross‐sectional survey	49
P1‐15: Chest X‐ray improvement in COVID‐19 moderate symptoms with remdesvir and favipiravir: A comparative study	47
P1‐66: Metastatic pulmonary calcification mimicking miliary pulmonary tuberculosis: A case report	44
P8‐26: Study of the number of courses required for the first response to immune checkpoint inhibitor (+chemo) therapy for lung cancer	43
O5‐4: The effects of smoking cessation therapy on pulmonary function and predictive factor of the FEV1 increase	41
O18‐5: Sleep apnea and academic performance: A study on medical students using the Berlin questionnaire	40
O20‐1: Spinal cord infarction after bronchial artery embolization using coils for hemoptysis: A single‐center retrospective analysis of 3046 procedures	40
P16‐93: Preliminary analysis of serum risk factors during an acute exacerbation of chronic fibrosing interstitial pneumonia: A multi‐institutional prospective study	37
P6‐36: Components system of nitric oxide as markers of pulmonary multi‐drug resistant tuberculosis process activity	36
O3‐6: The Pulmonary Endothelium Plays a Critical Role in the Fibrotic Response to Lung Injury through S1PR1 and ROCK Mediated Cytoskeletal Rearrangements	36
P12‐21: The recommended image features of peripheral lung parenchymal targets for diagnosis by CT‐guided needle biopsy	35
P8‐83: Giant pleuro parenchymal metastases from a rare primary tumor	34
P1‐88: Persistent bilateral unprovoked pulmonary embolism ‐ A case of chronic thromboembolic pulmonary hypertension in a young lady with seronegative antiphospholipid syndrome	34
P6‐28: Clinical case of using intravenous forms of anti‐tuberculosis drugs to improve the treatment efficiency of tuberculosis in patients with malabsorption syndrome (MS)	34
P5‐55: What kind of disease has developed in a teenager against the background of a new coronavirus infection? Is it Kawasaki's or Reye's syndrome?	33
P9‐27: Clinical feature and effectiveness of benralizumab therapy for severe asthma	33

	32
P11‐8: Surviving covid: A case report on the first covid survivor after extracorporeal membrane oxygenation (ECMO) in the Philippines	32
P9‐85: The reaction of the pituitary‐adrenal system to cold bronchoprovocation in asthma patients with subclinical hypothyroidism	32
Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients	31
Influence of Staphylococcal enterotoxin‐specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma	30
Bayesian adaptive clinical trial designs for respiratory medicine	30
APSR 2024 Abstracts	28
Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk	28
Omics technologies to study virus infection and chronic lung diseases	27
Language concordance in healthcare: Beyond just talk	27
Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes	26
Improving support of informal carers of respiratory patients	26
Proteomic and other ‘‐omic’ analyses to develop disease stage‐specific platforms and therapeutic strategies for COPD: It is about time	26
Prevention of droplet dispersal with ‘e‐mask’: A new daily use endoscopic mask during bronchoscopy	26
Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement	25
Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study	25
Decline in respiratory and cardiac admissions during the COVID‐19 pandemic: What is the role of common respiratory virus infections?	25
	24
Response to “Fixed CPAP at 10 cmH2O for OSA: A One‐Size‐Fits‐All Approach?”	24
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019	24
The Assessment of Subglottic and Cervical Tracheal Stenosis Using a Novel Point‐of‐Care Ultrasound Method: Measurement of Tracheal Radius Curvature	24
	23
Issue Information	23
O23‐1: Clinical features of novel phenotype in pulmonary hypertension along with mild lung parenchymal change without severe ventilatory impairment	22
P5‐155: Legionella pneumophilia pneumonia with rapid clinical course in a lung cancer patient	21
O8‐2: Clinical impact by phenotyping empyema based on pleural fluid culture positivity and appearance: A 7‐year retrospective analysis	21
P7‐43: The impact of fungal sensitization on clinical features in asthma and chronic pulmonary obstructive disease	20
P6‐9: A post covid activation of latent tuberculosis	20
P15‐3: Potential amelioration of pulmonary hypertension in COPD by budesonide/glycopyrronium/formoterol via central NFκB inflammatory signaling deactivation: In vivo mouse model	19
P2‐42: Effects of protease‐activated receptor antagonist on steroid insensitive airway inflammation induced by LPS in mice	19
P7‐49: Clinical experience of budesonide/glycopyrrolate/formoterol in patients with chronic obstructive pulmonary disease	18
P16‐71: Factors associated with pulmonary function decline in patients with rheumatoid arthritis‐associated interstitial lung disease	18
P16‐86: Tolerability and safety of nintedanib for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung diseases	18
P12‐32: Cryo‐recanalization in a case of recurrent endobronchial diffuse large B‐cell lymphoma	18
P5‐39: Impact of chronic co‐infection in pulmonary Mycobacterium avium complex disease after commencing treatment	17
O9‐1: Urticaria—A Major systemic drug reaction under 1HP tuberculosis prevention in non‐HIV population	17
P16‐49: Analysis of lymphocyte fractions in bronchoalveolar lavage fluid in chronic eosinophilic pneumonia	16
O2‐2: Development and implementation of an aspiration pneumonia diagnostic algorithm for the practical application of the JRS guidelines	16
P16‐48: The prognostic marker of polymyxin B‐immobilized fiber column‐direct hemoperfusion in patients who developed acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia	16
P6‐43: Multicenter Prospective Study on Gouty Arthritis and Predictors of Outcomes among Filipino Patients on Anti‐Tuberculosis Treatment	16
P8‐18: Analysis of trace element concentrations and relationship between trace element and prognosis in lung cancer patients	16
P12‐24: Tracheo‐ bronchial stenosis‐ different clinical presentations and individualised treatment approach	15
P6‐29: A case of elderly female with unresponsive anti‐tuberculosis therapy in rural area	15
P9‐55: Inhaler techniques and confidence of use of inhalers	15
P16‐96: Efficacy and safety of combination therapy of antifibrotic agents in patients with idiopathic pulmonary fibrosis	15
P2‐46: Effect of high fat diet on the severity and repair of lung fibrosis in mice	15
P1‐83: A case report of primi 30 weeks of pregnancy with COVID‐19 pneumonia with dengue fever	15
P4‐23: A case report of bronchial anthracofibrosis – A Sri Lankan experience	15
P1‐12: Eosinophilic granulomatosis with polyangiitis (Churg Strauss syndrome) presenting as acute polyneuropathy mimicking Guillain‐Barre syndrome ‐ A case report	15
Enhancing COPD Care for Women: A Predictive Tool for Palliative Needs	14

	14
A New Opportunity in Respirology	14
Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis	14
Issue Information	14
Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology E	14
Singing in and out of COVID	13
Safety and efficacy of bronchial thermoplasty in Australia 5 years post‐procedure	13
Unravelling the effects of omalizumab on fibrocytes	13
Obesity is a major contributing cause of breathlessness in the population	13
From light to sound: Ultrasound outshines Light's criteria for pleural effusions classification	13
Letter from Canada: Global warming and wildfire smoke pollution emerging as major threats to respiratory health	13
The chicken or the egg: Sleep or physical activity?	13
Allele‐specific micro‐RNA‐mediated regulation of ADAM33 in childhood allergic asthma	13
Stepping down for mild asthma and disadvantages of the ‘as‐needed’ strategy—Perspectives from a developing country	13
Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis	12
Adding some NOVELTY to treatable traits	12
Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non‐Responders in IPF?	12
Smoking, respiratory symptoms, lung function and life expectancy: A longitudinal study of ageing	12
Associations of early life and childhood risk factors with obstructive sleep apnoea in middle‐age	12
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study	12
P8‐50: Lung cancer, as a risk factor for abdominal aortic aneurysm (AAA)	11
P16‐16: The role of statins on the risk of the cancer among the interstitial lung diseases and pulmonary fibrosis: A time‐dependent in propensity‐matched general population study focus on the immunolo	11
Abstract	11
P16‐55: Additional effects of macrolides on steroid pulse therapy in patients with acute exacerbation of interstitial lung disease	11
O1‐4: Prognosis of Japanese patients with late‐onset non‐infectious pulmonary complications after hematopoietic stem cell transplantation registered for lung transplantation	11
P9‐21: Inhaled corticosteroids for all asthma	11
P5‐48: Shrot versus long antibiotic course for pleural infection management: A randomised trial	11
P8‐31: Prospective observational study of sequential afatinib and osimertinib in NSCLC patients with EGFR mutation: Gio‐Tag Japan	11
P12‐36: Bronchoscopic cryo‐excision of a large chondroid hemartoma presented as right middle lobe collapse in a 63 yrs gentleman	11
P4‐24: Respiratory symptoms and lung function among active smokers in Indonesian college students	10
O4‐2: Serum albumin in furry animals as a cross‐reactive component may cause more severe allergic symptoms	10
P9‐80: Exposures to cigarette smoke and house dust in relation to child asthma at Harum Melati Clinic, Pringsewu Regency, Lampung, Indonesia	10
P3‐13: IL‐17A acutely modulates airway smooth muscle contractility by PKC‐alpha‐mediated RhoA activation	10
P7‐5: Sex‐specific differences of prevalence and risk factors for chronic obstructive pulmonary disease in subjects with preserved ratio impaired spirometry	10
P16‐50: Clinical features of pleuroparenchymal fibroelastosis: Idiopathic versus secondary phenotype	10
P6‐22: Characteristics of pulmonary tuberculosis with delayed diagnosis in our hospital	10
P5‐89: Effectiveness of a questionnaire to screen COVID‐19	10
P8‐4: An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma	10
P7‐29: Muscle mass evaluation using body composition analysis for COPD patients	9
P16‐34: Clinical investigation of the relationship between interstitial lung disease and obstructive sleep apnea	9
Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis	9
Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD: Evidence from NHAN	9
P1‐94: The challenges of patients that with home using long term oxygen therapy under coronavirus pandemic	9
P16‐83: HRCT scoring focused on ground‐glass opacity, perilobular opacity, airspace consolidation, and interlobular septal thickening is useful for interstitial lung disease accompanied by anti‐MDA5 a	9
	9
P9‐77: The correlation of childhood asthma and family history of atopy in Harum Melati clinic, Pringsewu, Lampung, INDONESIA	9
P8‐86: Puncture frequency is the determinants of iatrogenic pneumothorax in preoperative pulmonary nodule localization: A propensity matched study	9
Corrigendum	9
Transitional Lung Function Paths in Young Adults: More Opportunities for Prevention?	9
Letter from Vietnam	9
	8
Corrigendum	8
P3‐9: Allergy in IgG4‐related disease	8
Issue Information	8
P5‐151: Changes over time in six‐minute walk test and the SGRQ scores in patients with nontuberculous mycobacterial pulmonary disease	8
Thoracic Society of Australia and New Zealand (TSANZ) Is Abrogating Its Leadership Role in Asia‐Pacific	8
Abstracts	8
An additional mechanism enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula	8
P5‐149: Investigation of antibody level by the presence or absence of side effects after the new coronavirus vaccine	8
Issue Information	8
Issue Information	8
P5‐57: Comparison of chest HRCT findings between COVID‐19 pneumonia and anti‐MDA5 antibody‐positive interstitial pneumonia by computer‐based quantitative CT image analysis	8
Issue Information	8
P6‐65: A case of tuberculosis infection with a particular clinical course and difficulty in treatment	8
P5‐37: Community‐acquired respiratory virus cases mimic COVID‐19 on lung computed tomography	8
Efficacy and safety of virtual bronchoscopic navigation with fused fluoroscopy and vessel mapping for access of pulmonary lesions	8
P5‐25: Spontaneous development of pneumocystis pneumonia in mice lacking death ligand‐induced apoptosis and necroptosis	8
Uncontrolled mild‐to‐moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping	7
Sleep medicine is more than just obstructive sleep apnoea	7
A snorkel mask with a 3D‐printed adaptor to HEPA filter was used in a COVID‐19 emergency ward to provide safe respiratory support	7
A Comprehensive Review of Interstitial Lung Abnormalities	7
Chest x‐ray has low sensitivity to detect silicosis in artificial stone benchtop industry workers	7
Letter from Australia	7
Promotion of physical activity after hospitalization for COPD exacerbation: Aids and barriers	7
My Lungs Have Feelings Too!	7
Pneumothorax in Endobronchial Valve Therapy–Still a Lot to Be Learned	7
Author Index	7
The 63rd Annual Meeting of the Japanese Respiratory Society	7
Laryngeal hypersensitivity and abnormal cough response during mannitol bronchoprovocation challenge	7
Severe asthma, more than that?	7

The Olympics have arrived: The challenge of exercise‐induced bronchoconstriction in athletes	7
A New Era in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis	7
	7
O22‐5: Complete pulmonary function profiles of 267 post COVID patients with exertional dyspnea in Bangladesh	6
P2‐39: Assessment of inter‐lobe biological diversity in the lung by DNA methylation profiles in autopsy cases	6
P7‐6: The association between alkaline phosphatase and COPD symptoms, severity, and exacerbation	6
P7‐39: Evaluation of the effect of ICS containing triple therapy with LAMA/LABA in comparison with LAMA/LABA in COPD patients	6
Author Index	6
P8‐128: Phase II trial of pembrolizumab in poor performance status NSCLC patients with PD‐L1 ≥ 50%: OLCSG 1801	6
P2‐33: Blocking MMP‐12‐modulated epithelial‐mesenchymal transition by repurposing penfluridol retsrains lung adenocarcinoma metastasis via UPA/UPAR/TGF‐Β/AKT pathway	6
P9‐39: Efficacy of vitamin d supplementation in children with asthma and vitamin D deficiency: A systematic review	6
P6‐23: Diagnostic utility of adenosine deaminase (ADA) activity in pleural fluid and pleural fluid lactate dehydrogenase/ADA ratio of tuberculous and non‐tuberculous pleural disease	6
P7‐33: The different significance between sedentary time and high‐intensity physical activities in patients with stable COPD	6
P6‐61: Association of serum antibodies against the Mycobacterium avium complex with hemoptysis	6
P8‐69: Clinical study of chemotherapy with an immune checkpoint inhibitor combination chemotherapy in advanced small cell lung cancer	6
P10‐14: Long term follow‐up in pediatric OHS/OSA treated conservatively: Survival tips beyond home ventilation	6
P8‐170: A patient with ALK translocation‐positive lung adenocarcinoma in whom an EGFR mutation developed during the treatment with ALK inhibitors	6
P5‐56: Predictive model for the development of critical coronavirus disease 2019 in Japan	6
P3‐1: Differential model of the deep convolutional neural network between sarcoidosis and lymphoma in 18F‐FDG‐PET/CT	6
P3‐2: Impact of air pollutant of polycyclic aromatic hydrocarbons (PAHS) on the yearly decline of pulmonary function in asthmatics sensitized to house dust mite (HDM)	6
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study	5
Attenuation of exertional desaturation and preference for interval exercise compared to continuous exercise in people with interstitial lung disease	5
Issue Information	5
Author Index	5
P8‐95: Correlation of neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR) and carcinoembryonic antigen (CEA) with overall survival: Review of patients with non‐small cell carcinoma (NSC	5
P6‐2: To study the efficacy and safety of bedaquiline plus optimized background regimen and high dose moxifloxacin plus optimized background regimen in drug resistant pulmonary tuberculosis‐A prospect	5
	5
The United Nations Framework Convention on Climate Change (UNFCCC) 28th Conference of the Parties, Dubai (COP28): Implications for lung disease	5
Leading Women in Respiratory Clinical Sciences: Letter From Japan	5
High Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial	5
Hansen's disease and the first patient disease Registry	5
Transformative radiology: Chest imaging is being re‐defined	5
Correction to APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong. Respirology 29 (Suppl. 3)	5
P13‐3: Withdrawn	5
P16‐67: Kinetic changes of serum KL‐6 levels predict disease progression in systemic sclerosis‐associated interstitial lung disease	5
P16‐56: The effect of pulmonary macrophage transplantation on mice with bleomycin‐induced pulmonary fibrosis	5
Validation of the clinical utility of sGaw as a response variable in methacholine challenge testing	5
P8‐145: Successful immune checkpoint inhibition in an EGFR‐TKI‐refractory lung cancer with EGFR mutation and transformation	5
Association of short‐term exposure to PM1 with hospital admission from total and cause‐specific respiratory diseases	5
Predictors of psychological stress in silica‐exposed workers in the artificial stone benchtop industry	5
Letter from Korea	5
Presence of anti‐modified protein antibodies in idiopathic pulmonary fibrosis	5
	5
Letter from the United States: An update on the New York experience with COVID‐19	5
P8‐80: Bevacizumab suppresses epithelial‐to‐mesenchymal transition in EGFR‐mutant lung cancer	5
P1‐48: Metabolism of traditional Chinese medicine in the treatment of allergic rhinitis	5
Global, regional and national burden of chronic obstructive pulmonary disease over a 30‐year period: Estimates from the 1990 to 2019 Global Burden of Disease Study	5
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe	5
Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions	5
	4
P1‐62: Elderly sarcoidosis in Japan	4
P10‐20: Sleep and the usage of smart devices among Sri Lankan doctors	4
Determinants of radiation exposure during mobile cone‐beam CT‐guided robotic‐assisted bronchoscopy	4
P8‐30: Usefulness of pulmonary rehabilitation in non‐small cell lung cancer patients based on pulmonary function tests and muscle index analysis using computed tomography images	4
P5‐85: Staged treatment of middle lobe lung gangrene using the vacuum‐assisted closure therapy in a patient with severe COVID‐19 pneumonia	4
O17‐4: Novel predictive biomarkers for mepolizumab treatment in patients with severe asthma	4
O18‐4: Non‐invasive ventilation improves persistent tachycardia in a case of mitochondrial myopathy	4
Innovations in thoracic imaging: CT, radiomics, AI and x‐ray velocimetry	4
P2‐15: An HTERT/CDK4‐immortalized normal human bronchial epithelial cell line is highly resistant to mutant KRAS‐induced senescence	4
P9‐67: Adherence to inhaled corticosteroids in working‐age patients with asthma: A non‐interventional study with secondary use of data	4
	4
Issue Information	4
P5‐114: A young lady with bones in the lungs –A case of diffuse pulmonary fibro ossification complicated with fungal infection	4
P1‐77: Long‐COVID syndrome associated with COVID‐19 pneumonia	4
P12‐38: A young woman with bilateral primary spontaneous pneumothorax	4
P12‐28: Bronchiolitis obliterans after bone marrow transplantation diagnosed by ultrathin bronchoscopy: A case report	4
P15‐4: Pulmonary vasculopathy in pulmonary hypertension with interstitial lung disease: A morphometric study of autopsy cases	4
P6‐44: Case report of a newly diagnosed bacteriologically confirmed pulmonary tuberculosis in a patient with COVID‐19 critical infection	4
P8‐10: Minichromosome maintenance complex component (MCM) genes in lung adenocarcinoma: MCM‐family acts as a potential therapeutic target	4
P16‐97: Secondary organizing pneumonia following COVID‐19 infection	4
P6‐4: Endobronchial mass occurred during treatment of tuberculosis: Two cases	4
Issue Information	4
A visit to the gallery	4
Issue Information	4
P16‐62: The prognostic factor of idiopathic interstitial pneumonias patients complicated with pneumothorax: A multicenter retrospective study	4
P5‐68: The use of an institutionalized respiratory protocol as a decision‐making tool improved outcomes among severe and critically‐ill COVID‐19 patients in Perpetual Succour Hospital	4
P7‐66: Clinical inertia in the management of COPD: A review of the literature	4
P5‐111: SARS‐CoV‐2 PCR and antigen positivity continued for 3 months after treatment for severe COVID‐19: Case report	4
P12‐3: Diagnostic efficacy of cryobiopsy for peripheral pulmonary lesions with ground‐glass opacity: A propensity score‐matched analysis	4
P16‐53: Effectiveness of antifibrotic treatment for acute exacerbation of idiopathic pulmonary fibrosis	4
P8‐84: S‐1 reduces myeloid‐derived suppressor cells in murine mesothelioma model and enhances the anti‐tumor activity of anti‐PD‐1 antibody	4
O4‐5: Combination of tryptase and IL‐33 in bronchoalveolar lavage fluid may predict the types of eosinophilic pneumonia and disease recurrence	4
O2‐4: Prevalence, characteristics, risk factors and disease course of ulcerative colitis‐related pulmonary manifestations	4
P8‐139: A case of pulmonary mucoepidermoid carcinoma treated with carboplatin, nab‐paclitaxel, and pembrolizumab	4
P13‐1: Chest X‐ray findings of coronavirus‐19 disease in patients age 0 to 18 years old admitted at Chong Hua Hospital from March 2020 to February 2021	4
Correction to “APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong. Respirology 29 (Suppl. 3)”	4
Issue Information	4
P6‐18: Endobronchial ultrasound transbronchial aspiration biopsy (EBUS‐TBNA) in the diagnosis of mediastinal mass of unknown etiology: A case series	3
P7‐25: The mortality difference in chronic obstructive pulmonary disease: Ever‐smoker versus never‐smoker	3
P8‐64: Optimal dose of amrubicin for previously treated small‐cell lung cancer: A retrospective study	3
P8‐12: The relationship between lung microbiota and pathologic subtype with prognosis	3
P5‐21: Serum ferritin levels: A cost‐effective marker for severity of pneumonia in patients with COVID 19	3
P8‐67: A retrospective study of recurrence patterns in chemoradiotherapy using volumetric modulated arc therapy for locally advanced non‐small cell lung cancer	3
P5‐120: Withdrawn	3
P1‐20: Adulthood presentation of congenital pulmonary airway malformation type‐1	3